聖諾醫藥（02257）刊发截至2025年12月31日止的股份变动月报表，公告日期为2026年1月6日。报告显示，公司法定股本维持230,000,000股，面值每股0.001美元，总额保持不变，为230,000美元。
截至2025年12月31日，公司已发行股份由上月末的106,217,838股增至107,221,538股，增加部分为1,003,700股普通股。该批新增股份于2025年12月8日完成发行，每股认购价格为12港元。期内并无购回或注销股份，公司库藏股数量亦保持为零。此外，根据公司股份期权计划，本月内因期权失效减少4,099份期权，未有因行使期权产生新股发行或库藏股份变动。公司确认已遵守香港联合交易所有限公司《上市规则》及相关法规，公告由公司秘书袁潤廷签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.